Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-07-2008 | Focus on

The power of synergy in the mediastinal staging of lung cancer

Author: Giovanni Lucignani

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 7/2008

Excerpt

In lung cancer patients without distant metastases, the status of the mediastinal lymph nodes is a key determinant of therapy and prognosis, often calling for invasive staging with pathological verification. The synergic use of invasive and non-invasive techniques is an important option that we should not allow ourselves, through narrow-mindedness, to overlook. Greater understanding of the potential and challenges offered by the different staging methods, and of the effectiveness of their combined use, may help us to optimise the diagnosis and treatment of these patients. …

Vilmann P, Puri R. The complete “medical” mediastinoscopy (EUS-FNA + EBUS-TBNA). Minerva Med 2007;98(4):331–8, August.PubMed

Wallace MB, Pascual JM, Raimondo M, Woodward TA, McComb BL, Crook JE, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008;299(5):540–6, 6 February.PubMedCrossRef

Craanen ME, Comans EF, Paul MA, Smit EF. Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2007;6(4):433–6, August.PubMedCrossRef

Hsu LH, Ko JS, You DL, Liu CC, Chu NM. Transbronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography. Respirology 2007;12(6):848–55, November.PubMedCrossRef

Bauwens O, Dusart M, Pierard P, Faber J, Prigogine T, Duysinx B, et al. Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients. Lung Cancer 2008;in press. doi:10.1016/j.lungcan.2008.01.005.

Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and PET normal mediastinum in patients with lung cancer. Chest 2008;133(4):887–91.PubMedCrossRef

De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32(1):1–8, July.PubMedCrossRef

Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):178S–201S, September.PubMedCrossRef

Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA, American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):202S–20S, September.PubMedCrossRef

10.

Whitson BA, Groth SS, Maddaus MA. Recommendations for optimal use of imaging studies to clinically stage mediastinal lymph nodes in non-small-cell lung cancer patients. Lung Cancer 2008;in press. doi:10.1016/j.lungcan.2007.12.019.

Title: The power of synergy in the mediastinal staging of lung cancer
Author: Giovanni Lucignani
Publication date: 01-07-2008
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-008-0812-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The power of synergy in the mediastinal staging of lung cancer

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2008

18F-FDG PET/CT imaging in tendon xanthomatosis

The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee

Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons

18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort?

ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine

Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases